Search Results

• On behalf of the CoVIg-19 Plasma Alliance and other plasma companies, Perreault urges people who have recovered from COVID-19 to consider donating plasma. To learn how and where to donate plasma, please visit TheFightIsInUs.org.

https://www.csl.com/news/2020/20200730-perreault-urges-plasma-donations-at-white-house-roundtable

The Alliance’s anti-COVID-19 Hyperimmune Globulin (CoVIg-19) medicine is under evaluation as part of the trial and may become one of the earliest treatments for hospitalized individuals at risk for serious complications of COVID-19

https://www.csl.com/news/2020/20201009-first-patient-enrolled-in-nih-covid19-phase-3-trial

Prior to Takeda, Dr Yamada was President of the Bill & Melinda Gates Foundation Global Health Program and prior to that was Chairman of Research and Development at GlaxoSmithKline.

https://www.csl.com/-/media/csl/documents/february-2019-csl-prospectus_final.pdf

and Warner Lambert Co./Vice President Megan Clark, Current From 2016 Non-Executive Director Non-Executive Current From 2014 Director Rio Tinto Director Current From 2010 Bank of America Merrill Lynch/Member of Australian advisory board Past From 2009 to Commmonwalth Scientific and Industrial Research Organisation/ 2014 CEO Past From 2003 to BHP Billiton/ Vice President 2008 Tadataka Current From 2016 Non-Executive Director Yamada, Current From 2011 Agilent Technologies, Inc./ Director Non-Executive Current From 2015 Frazier Healthcare Partners/ Venture Partner Past From 2007 to Covidien/ Director Director 2011 Past From 2011 to Takeda Pharmaceuticals/ Chief Medical and Scientific Officer and 2015 Director Past From 2006 to Bill & Melinda Gates Global Health Program/ President 2011 Past From 2000 to GlaxoSmithKline/Chairman of R&D (2000-2006) and Director (2004- 2006 2006) Past From 1996 to SmithKline Beecham/Chairman of R&D and Director 2000 David Lamont, Current From 2016 Chief Financial Officer Chief Financial Past From 2010 - MMG/CFO Officer 2016 Past From 1999 to Served as CFO of several leading multinational companies including Past 2010 MMG Limited, Oz Minerals Limited, PaperlinX Limited, BHP Bil- lington's energy and coal and carbon steel materials division and Incitec Pivot Limited Andrew Cuth- Current From 2000 Chief Scientific Officer and R&D Director.

https://www.csl.com/-/media/shared/documents/approved-csl-prospectus-for-communication.pdf

He has also held the role Dr Tadataka Yamada of President on the Bill & Melinda Gates Foundation Global Health Program has been a Director and prior to that was Chairman of Research and Development at of CSL Limited since GlaxoSmithKline.

https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf